| Financial Year |
March 31 2023 |
| Monetary Funds |
6,225,393,294.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
125,284,560.99 |
| Accounts Receivable |
13,483,301,817.31 |
| Advances to Suppliers |
1,726,603,286.07 |
| Other Receivables |
522,968,036.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
13,030,494.13 |
| Inventories |
17,271,537,839.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
603,078,229.79 |
| Total Current Assets |
41,336,879,983.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,428,075,459.18 |
| Investment Properties |
80,686,942.36 |
| Fixed Assetes |
5,560,957,557.99 |
| Under-construction Projects |
895,678,055.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,548,885,679.86 |
| R&D expenses |
108,540,350.88 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
475,899,389.05 |
| Deferred Income Tax Assets |
174,891,963.63 |
| Other Non-Current Assets |
1,950,388,021.43 |
| Sub-Total of Non-Current Assets |
12,775,399,444.36 |
| Total Assets |
54,112,279,427.71 |
| Short-Term Loans |
262,590,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,096,758,598.08 |
| Accounts Payable |
13,528,301,565.99 |
| Accounts Received In Advance |
219,067,657.70 |
| Employee Compensation Payable |
32,923,141.09 |
| Taxes Payable |
434,288,366.52 |
| Interest Payable |
-- |
| Dividend Payable |
101,271,982.59 |
| Other payables |
1,178,243,283.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
310,321,459.12 |
| Other Current Liabilities |
438,306,191.70 |
| Sub-Total of Current Liabilities |
28,305,437,413.45 |
| Long-term Loans |
62,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
385,716,028.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
63,860,171.61 |
| Other Non-Current Liabilities |
2,286,024.69 |
| Sub-Total of Non-Current Liabilities |
730,814,632.91 |
| Total Liabilities |
29,036,252,046.36 |
| Paid-In Capital(Or Share Stock) |
2,221,551,588.00 |
| Capital Surplus |
5,396,264,002.77 |
| Surplus Reserve |
788,910,763.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,323,100,804.55 |
| Minority Stockholder's Interest |
619,716,744.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,456,310,636.68 |
| Owner's Equity（Stockholder's Equity） |
25,076,027,381.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
54,112,279,427.71 |
